Class Action Lawsuit Filed Against Immutep Limited (NASDAQ: IMMP) for Alleged Securities Fraud

A securities class action lawsuit has been filed against Immutep Limited (IMMP), alleging violations of the Securities Exchange Act. The suit claims that false statements were made regarding a clinical trial, misleading investors between March 2025 and March 2026.

By The Schall Law Firm · PR Newswire ·

Class Action Lawsuit Filed Against Immutep Limited (NASDAQ: IMMP) for Alleged Securities Fraud

Tickers: $IMMP

Topics: class action lawsuit Rule 10b-5 Securities Exchange Act of 1934

Read the full article at PR Newswire

More Politics news